Imagine two people standing on a stretchy sheet. When one pulls, the other feels the fabric move...
fibrosis
Results revealed at The International Liver Congressâ„¢ 2015 demonstrate current treatment and prevention programmes need to be...
New data presented at The International Liver CongressTM 2015 show that the intensity of weight loss induced...
The U.S. Food and Drug Administration approved Ofev (nintedanib) for the treatment of idiopathic pulmonary fibrosis (IPF).
A pre-specified subgroup analysis from the two replicate Phase III INPULSISâ„¢ trials, presented at the European Respiratory...
Roche and InterMune, Inc. announced they have entered into a definitive merger agreement for Roche to...
For the first time, scientists have succeeded in transforming human stem cells into functional lung and airway...
Living close to a busy road is associated with a higher risk of death in people with...
The U.S. Food and Drug Administration approved TOBI Podhaler (tobramycin inhalation powder) for the management of cystic...
Multi-center program focusing on infants and young children could provide a roadmap for prevention Researchers will study...
